YX-2-107
CAS No. 2417408-46-7
YX-2-107 ( —— )
产品货号. M36609 CAS No. 2417408-46-7
YX-2-107 是一种选择性降解 CDK6 的 PROTAC (IC50= 4.4 nM)。YX-2-107 在体外能有效抑制 RB 磷酸化和 FOXM1 表达,并抑制大鼠体内 Ph+ ALL 的发展。YX-2-107 可用于 Ph 染色体阳性 (Ph+) 急性淋巴细胞白血病 (ALL) 的研究。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ¥2920 | 有现货 |
|
| 5MG | ¥4546 | 有现货 |
|
| 10MG | ¥7243 | 有现货 |
|
| 25MG | ¥12981 | 有现货 |
|
| 50MG | ¥19472 | 有现货 |
|
| 100MG | ¥25704 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称YX-2-107
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述YX-2-107 是一种选择性降解 CDK6 的 PROTAC (IC50= 4.4 nM)。YX-2-107 在体外能有效抑制 RB 磷酸化和 FOXM1 表达,并抑制大鼠体内 Ph+ ALL 的发展。YX-2-107 可用于 Ph 染色体阳性 (Ph+) 急性淋巴细胞白血病 (ALL) 的研究。
-
产品描述YX-2-107 is a PROTAC (IC50= 4.4 nM) that selectively degrades CDK6. YX-2-107 effectively inhibits RB phosphorylation and FOXM1 expression in vitro and inhibits the development of Ph+ ALL in rats. YX-2-107 can be used in the study of Ph chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL).
-
体外实验YX-2-107 (2000 nM; 48 h) shows inhibition of S phase in Ph+ BV173 and SUP-B15 cells.YX-2-107 (0, 1.6, 8, 40, 200, 1000 nM;4 h) selectively degrades CDK6 in BV173 cells.YX-2-107 (2000 nM; 72 h) inhibits RB phosphorylation and FOXM1 expression in Ph+ BV173 and SUP-B15 cells.Cell Cycle Analysis Cell Line:Ph+ BV173 and SUP-B15 cells Concentration:2000 nM Incubation Time:48 h Result:Inhibited S-phase entry.Western Blot Analysis Cell Line:Ph+ BV173 and SUP-B15 cells Concentration:2000 nM Incubation Time:72 h Result:Inhibited the phosphorylation of RB and the expression of FOXM1.
-
体内实验YX-2-107 (10 mg/kg; i.p.; single) shows a maximum concentration of 741 nM (150-fold greater than CDK6 degradation IC50), with clearance from the plasma after 4 hours.YX-2-107 (150 mg/kg; i.p.; single daily for 3 days) is pharmacologically active in suppressing Ph+ ALL proliferation in mice.Animal Model:NRG-SGM3 mice (Ph+ ALL xenografts model).Dosage:150 mg/kg Administration:Intraperitoneal injection; single daily for 3 days Result:Suppressed the percentage of primary Ph+ ALL S-phase cells, the expression of CDK4/6-regulated phospho-RB and, to a lesser degree, FOXM1, and induced the selective CDK6 degradation.Animal Model:C57BL/6j mice.Dosage:10 mg/kg Administration:Intraperitoneal injection.
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体PROTACs | CDK
-
研究领域——
-
适应症——
化学信息
-
CAS Number2417408-46-7
-
分子量889.95
-
分子式C45H51N11O9
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO 中的溶解度 : 100 mg/mL (112.37 mM; 超声助溶 )
-
SMILESO=C1NC(=O)C(N2C(=O)C=3C=CC=C(OCC(=O)NCCCCNCC(=O)N4CCN(C5=CN=C(C=C5)NC=6N=CC7=C(N6)N(C(=O)C(C(=O)C)=C7C)C8CCCC8)CC4)C3C2=O)CC1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. De Dominici M, et al. Selective inhibition of Ph-positive ALL cell growth through kinase-dependent and -independent effects by CDK6-specific PROTACs. Blood. 2020 Apr 30;135(18):1560-1573.?
产品手册
关联产品
-
1-(2-fluorophenyl)-3...
1-(2-fluorophenyl)-3-[5-(2-methoxyphenyl)-1,3,4-thiadiazol-2-yl]urea is a chemical compound.
-
MFCD28987368
MFCD28987368 是一种化合物。
-
Fz7-21 TFA
Fz7-21 TFA ((Ac)-LPSDDLEFWCHVMY-NH2 TFA), a peptide antagonist of Frizzled 7 (FZD 7) receptors, selectively binds to FZD7 CRD subclass. The EC50 values are 58 and 34 nM for human and mouse FZD7 CRD, respectively.
021-51111890
购物车()
sales@molnova.cn

